Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPI-743 for Noise-Induced Hearing Loss
NCT02257983Phase 2Completed
- Sponsor
- Bioelectron
- Start
- Oct 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatiquinone in noise-induced hearing loss (NIHL), sponsored by Bioelectron. Started Oct 2014; status: completed.
02
Drugs
vatiquinone
03
Conditions
noise-induced hearing loss (NIHL)
Beyond the preview
Go deeper on NCT02257983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257983.